Last CNY26.55 CNY
Change Today +1.00 / 3.91%
Volume 3.6M
300255 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:00 AM 04/18/14 All times are local (Market data is delayed by at least 15 minutes).

hebei changshan biochemica-a (300255) Snapshot

Open
CNY25.55
Previous Close
CNY25.55
Day High
CNY26.79
Day Low
CNY25.55
52 Week High
08/28/13 - CNY30.00
52 Week Low
06/25/13 - CNY16.73
Market Cap
5.0B
Average Volume 10 Days
1.6M
EPS TTM
CNY0.61
Shares Outstanding
188.4M
EX-Date
06/6/13
P/E TM
43.5x
Dividend
CNY0.10
Dividend Yield
0.38%
Current Stock Chart for HEBEI CHANGSHAN BIOCHEMICA-A (300255)

Related News

No related news articles were found.

hebei changshan biochemica-a (300255) Related Businessweek News

No Related Businessweek News Found

hebei changshan biochemica-a (300255) Details

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of heparin products in China and internationally. Its primary products comprise heparin sodium API, LMW heparin calcium injections, heparin sodium injections, sodium hyaluronate, and hard capsules, as well as Yihaitang capsules for anti-aging. The company was founded in 2000 and is based in Zhengding, China.

Founded in 2000

hebei changshan biochemica-a (300255) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

hebei changshan biochemica-a (300255) Key Developments

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Proposes Amendments to Articles of Association

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. announced that its 2013 annual general meeting to be held on April 25, 2014 will consider amendments to the company's articles of association.

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. to Report Fiscal Year 2013 Results on Apr 01, 2014

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. announced that they will report fiscal year 2013 results on Apr 01, 2014

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. to Report Q3, 2013 Results on Oct 19, 2013

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. announced that they will report Q3, 2013 results on Oct 19, 2013

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
300255:CH CNY26.55 CNY +1.00

300255 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 300255.
View Industry Companies
 

Industry Analysis

300255

Industry Average

Valuation 300255 Industry Range
Price/Earnings 42.3x
Price/Sales 6.7x
Price/Book 4.2x
Price/Cash Flow 42.2x
TEV/Sales 6.0x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HEBEI CHANGSHAN BIOCHEMICA-A, please visit www.heparin.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.